Emergent BioSolutions, a Gaithersburg, Maryland-headquartered specialty pharmaceutical company and contract manufacturer, has started a $50-million expansion to the company’s fill / finish facility in Baltimore, Maryland.

The multi-year expansion is expected to be completed in 2021 and is anticipated to create up to 60 new jobs in the next three years.

The multi-stage project includes the addition of a new isolator enclosed fill line. Emergent has partnered with Groninger & Co., a designer of pharmaceutical technology, to install its FlexPro 50 filler with isolator technology and an integrated Christ lyophilizer. This new line will have the capability of filling vials, syringes, and cartridges in a new fill suite with dedicated utilities. The company will also be adding a second autoclave to provide manufacturing redundancy and increased sterilization capacity, a new cold-storage space to support 2-8 degrees Celsius and -20 degrees Celsius requirements, new stability chambers, new media fill incubators, and additional warehousing and office space.

Source: Emergent BioSolutions